The Oxford-Harrington Rare Disease Centre initiates first disease priority area: Friedreich’s Ataxia
27 May 2021
The Oxford-Harrington Rare Disease Centre is redoubling efforts to develop a therapeutics programme for Friedreich’s Ataxia.
14 January 2020
Work will shortly be underway on the new IMS-Tetsuya Nakamura Building, home to the new Institute of Developmental and Regenerative Medicine at Old Road Campus. The formal ground-breaking ceremony, which took place towards the end of last year, was organised by the Department of Paediatrics in collaboration with the Medical Sciences Development team.
1 February 2017
Bernard Naughton and Dr David Brindley from Oxford University’s Saïd Business School and Medical Sciences Division discuss the problems of identifying fake, substandard and expired medicines.
28 June 2016
47 world leading UK researchers, including the Department's Georg Hollander and Andrew Pollard have been elected to the prestigious Fellowship of the Academy of Medical Sciences.
11 April 2016
You are invited to take part in a study to investigate how different vaccines prevent infection with Salmonella Typhi.
3 April 2016
A generous gift of £3.3million from the entrepreneur, private investor and philanthropist Mr André Hoffmann has secured the future of an Oxford Chair in Developmental Medicine.
1 March 2016
Measles is a highly infectious viral disease which can lead to serious complications. In high income regions of the world such as Western Europe, it causes death in at least 1 in 5000 cases, but as many as 1 in 100 will die in the poorest regions of the world.
25 November 2015
Shrijana Shrestha, Imran Ansari, Bibek Khadka & Sanjeev Bijukchhe talk about their experiences of the earthquakes that took place in Nepal this year. Sarah Kelly has added images to the soundtrack and originally presented it at the Oxford Vaccine Group away day. However, we wanted to share the moving stories here too for all to listen to.
15 July 2015
Oxford University doctors and scientists are performing the second phase of clinical studies of an experimental Ebola vaccine regimen. The study is part of the EBOVAC2 project, a collaborative programme involving the University of Oxford, French Institute of Health and Medical Research (INSERM) as project coordinator, London School of Hygiene & Tropical Medicine, Le Centre Muraz, Inserm Transfert (IT) and the Janssen Pharmaceutical Companies of Johnson & Johnson.
18 December 2014
Today’s Research Excellence Framework (REF 2014) results confirm the University of Oxford’s world leading position in medical sciences research.
8 October 2013
The Centre for Clinical Vaccinology and Tropical Medicine (CCVTM) marked its 10th Anniversary on Friday the 13th of September, with the unveiling of a plaque honouring Professor Richard Moxon, the founder of the Centre.